Azetidine and cyclobutane derivatives as JAK inhibitors
US8420629B2 · kind B2 · utility
90Cited by
6References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2011 |
| Grant date | Apr 16, 2013 |
| Priority date | — |
| Expiry date | Dec 9, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S362/802
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.